This site uses cookies, tags and tracking settings to store information that help give you the very best browsing experience. If you don't change your settings, we'll assume you're happy with this. More information Dismiss this warning

Reasons to publish

 

Rapid peer review and publication

 

Endocrine-Related Cancer is the premier global forum for basic, translational and clinical research on hormones and cancer, offering rapid peer review with a mean receipt to first response time of just 13 days. Accepted manuscripts are published online and fully citable within 24 hours of acceptance. Furthermore, articles are published continuously online as soon as the version of record is available i.e. just weeks from acceptance.

 

Maximise the reach of your work

 

Endocrine-Related Cancer’s latest Impact Factor is 4.1 (CiteScore 7.8). With a global readership, over 38,000 unique users worldwide access the journal online each month.

Where appropriate, published articles are promoted to scientists and clinicians from all over the world to ensure maximum reach and visibility of our authors’ work.

How we may promote your work

  • Press releases for papers of high interest and broad appeal.
  • Communications to members of the owning society, the Society for Endocrinology, and the endorsing societies, the Japanese Hormones and Cancer Society and the Endocrine Society of Australia, via multiple media.
  • Bioscientifica journals are promoted at c.40 conferences a year and your article may be picked to feature on our Themed Collection handouts.
  • Bimonthly email newsletters, including topic collections, sent to authors, readers, editors, reviewers and anybody else with an interest in the journal.
  • Summaries of selected papers feature as Hot Topics.

Tips for promoting your own work

 

Did you know that a Tweeted article is 11 times more likely to be cited up to 29 months after publication than an un-Tweeted article (Eysenbach 2011)?

Get the most out of your published article by considering the following:

  • You will receive a link to your published article which you can send to colleagues who may be interested in your line of research.
  • Add your article to the list of publications on your institution’s webpages. 
  • Use of social media: tweet your article and mention @soc_endo and @EndoCancer for a retweet.
  • Link to the paper in work-related blogs and professional websites.

 

Monitor the impact of your work with article level metrics

 

Article level metrics are available for articles published in Endocrine-Related Cancer. This feature provides traditional usage data (number of article downloads/views) as well as Altmetric data for individual articles published in the journal. Altmetric provide non-traditional data by tracking a selection of online indicators (both scholarly and non-scholarly) to give a measurement of digital impact and reach. This information is used to generate an article’s Altmetric Attention Score.

These article level metrics allow authors to monitor the impact of their research in academia and beyond.

 

Author experience

 

Bioscientifica Publishing prides itself on the provision of a personalised author service, and editorial office staff are on hand to offer assistance from submission through to publication. All authors are given the opportunity to provide feedback via an online survey, and in 2021, 60% of respondents indicated that their experience of publishing with Bioscientifica was better or much better than with other journal publishers*.

*Based on 464 respondents.

 

-